Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 318

1.

Risk of second primary cancer in oral squamous cell carcinoma.

Mroueh R, Nevala A, Haapaniemi A, Pitkäniemi J, Salo T, Mäkitie AA.

Head Neck. 2020 Feb 14. doi: 10.1002/hed.26107. [Epub ahead of print]

PMID:
32057158
2.

Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.

Almangush A, Leivo I, Mäkitie AA.

Acta Otolaryngol. 2020 Feb 5:1-3. doi: 10.1080/00016489.2020.1720284. [Epub ahead of print]

PMID:
32022615
3.

Histological characteristics of early-stage oral tongue cancer in young versus older patients: A multicenter matched-pair analysis.

Bello IO, Almangush A, Heikkinen I, Haglund C, Coletta RD, Kowalski LP, Mäkitie AA, Nieminen P, Leivo I, Salo T.

Oral Dis. 2020 Jan 29. doi: 10.1111/odi.13288. [Epub ahead of print]

PMID:
31994277
4.

Employment status of young otorhinolaryngologists in Finland during a 10-year period.

Penttilä E, Hannula S, Numminen J, Irjala H, Selander T, Parmanne P, Mäkitie A.

Int J Circumpolar Health. 2020 Dec;79(1):1715710. doi: 10.1080/22423982.2020.1715710.

PMID:
31967532
5.

The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective.

Nixon IJ, Shah JP, Zafereo M, Simo RS, Hay ID, Suárez C, Zbären P, Rinaldo A, Sanabria A, Silver C, Mäkitie A, Vander Poorten V, Kowalski LP, Shaha AR, Randolph GW, Ferlito A.

Eur J Surg Oncol. 2020 Jan 9. pii: S0748-7983(20)30014-7. doi: 10.1016/j.ejso.2020.01.010. [Epub ahead of print] Review.

PMID:
31952928
6.

Comparison of supervised machine learning classification techniques in prediction of locoregional recurrences in early oral tongue cancer.

Alabi RO, Elmusrati M, Sawazaki-Calone I, Kowalski LP, Haglund C, Coletta RD, Mäkitie AA, Salo T, Almangush A, Leivo I.

Int J Med Inform. 2019 Dec 28;136:104068. doi: 10.1016/j.ijmedinf.2019.104068. [Epub ahead of print]

PMID:
31923822
7.

Sinonasal Oncocytic Papilloma-A Series of 20 Cases With Special Emphasis on Recurrences.

Lilja M, Viitasalo S, Hytönen M, Haapaniemi A, Hagström J, Mäkitie A.

Laryngoscope Investig Otolaryngol. 2019 Sep 30;4(6):567-572. doi: 10.1002/lio2.308. eCollection 2019 Dec.

8.

Management of extracranial arteriovenous malformations of the head and neck.

Fernández-Alvarez V, Suárez C, de Bree R, Nixon IJ, Mäkitie AA, Rinaldo A, Downer J, Ferlito A.

Auris Nasus Larynx. 2019 Dec 17. pii: S0385-8146(19)30931-9. doi: 10.1016/j.anl.2019.11.008. [Epub ahead of print]

PMID:
31862283
9.

Exhaled breath analysis in the diagnosis of head and neck cancer.

Mäkitie AA, Almangush A, Youssef O, Metsälä M, Silén S, Nixon IJ, Haigentz M Jr, Rodrigo JP, Saba NF, Vander Poorten V, Ferlito A.

Head Neck. 2019 Dec 19. doi: 10.1002/hed.26043. [Epub ahead of print] Review.

PMID:
31854494
10.

A descriptive study highlighting the differences in the treatment protocol for oral tongue cancer in Sweden and Finland.

Mäkitie A, Kamali A, Mroueh R, Lindford A, Koivunen P, Autio T, Lassus P, Halle M, Bäck L, Palmgren B, Hammarstedt-Nordenvall L.

Acta Otolaryngol. 2020 Feb;140(2):188-194. doi: 10.1080/00016489.2019.1699663. Epub 2019 Dec 18.

PMID:
31852347
11.

Body Composition Evaluation in Head and Neck Cancer Patients: A Review.

Almada-Correia I, Neves PM, Mäkitie A, Ravasco P.

Front Oncol. 2019 Nov 7;9:1112. doi: 10.3389/fonc.2019.01112. eCollection 2019.

12.

The risk of second primary tumors in head and neck cancer: A systematic review.

Coca-Pelaz A, Rodrigo JP, Suárez C, Nixon IJ, Mäkitie A, Sanabria A, Quer M, Strojan P, Bradford CR, Kowalski LP, Shaha AR, de Bree R, Hartl DM, Rinaldo A, Takes RP, Ferlito A.

Head Neck. 2020 Mar;42(3):456-466. doi: 10.1002/hed.26016. Epub 2019 Nov 21.

PMID:
31750595
13.

Tonsillar surface swab bacterial culture results differ from those of the tonsillar core in recurrent tonsillitis.

Dickinson A, Kankaanpää H, Silén S, Meri S, Haapaniemi A, Ylikoski J, Mäkitie A.

Laryngoscope. 2019 Nov 20. doi: 10.1002/lary.28403. [Epub ahead of print]

PMID:
31747474
14.

Sclerosing sialadenitis of the submandibular gland is rarely an immunoglobulin G4-related disease in the Finnish population.

Peuraharju E, Saarinen R, Aro K, Mäkinen LK, Tarkkanen J, Mäkitie A, Haglund C, Hagström J, Atula T.

Mod Pathol. 2019 Nov 3. doi: 10.1038/s41379-019-0395-5. [Epub ahead of print]

PMID:
31680120
15.

Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance.

Saba NF, Chen ZG, Haigentz M, Bossi P, Rinaldo A, Rodrigo JP, Mäkitie AA, Takes RP, Strojan P, Vermorken JB, Ferlito A.

Mol Cancer Ther. 2019 Nov;18(11):1909-1915. doi: 10.1158/1535-7163.MCT-19-0214. Review.

PMID:
31676542
16.

An evidence-based analysis of the management of N0 neck in patients with cancer of the parotid gland.

Vartanian JG, Gonçalves Filho J, Kowalski LP, Shah JP, Suárez C, Rinaldo A, De Bree R, Rodrigo JP, Hamoir M, Takes RP, Mäkitie AA, Zbären P, Andreasen S, Poorten VV, Sanabria A, Hellquist H, Robbins KT, Bödeker CC, Silver C, Ferlito A.

Expert Rev Anticancer Ther. 2019 Oct;19(10):899-908. doi: 10.1080/14737140.2019.1674143. Epub 2019 Oct 8.

PMID:
31591950
17.

Early mortality after diagnosis of cancer of the head and neck - A population-based nationwide study.

Talani C, Mäkitie A, Beran M, Holmberg E, Laurell G, Farnebo L.

PLoS One. 2019 Oct 2;14(10):e0223154. doi: 10.1371/journal.pone.0223154. eCollection 2019.

18.

A preliminary Bayesian network model to identify factors associated with treatment outcome in T2 and T3 laryngeal carcinoma.

Haapaniemi A, Mäkitie A, Kekolahti P, Ryynänen OP.

Oral Oncol. 2019 Nov;98:162-164. doi: 10.1016/j.oraloncology.2019.09.007. Epub 2019 Sep 25. No abstract available.

PMID:
31561950
19.

Cricotracheal resection for adult subglottic stenosis: Factors predicting treatment failure.

Jethwa AR, Hasan W, Palme CE, Mäkitie AA, Espin-Garcia O, Goldstein DP, Gilbert RW, Keshavjee S, Pierre A, Gullane PJ.

Laryngoscope. 2019 Sep 9. doi: 10.1002/lary.28273. [Epub ahead of print]

PMID:
31498456
20.

Management of locally recurrent nasopharyngeal carcinoma.

Lee AWM, Ng WT, Chan JYW, Corry J, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, Suárez C, Vermorken JB, Yom SS, Ferlito A.

Cancer Treat Rev. 2019 Sep;79:101890. doi: 10.1016/j.ctrv.2019.101890. Epub 2019 Aug 21. Review.

PMID:
31470314

Supplemental Content

Loading ...
Support Center